The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor

GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world